A detailed history of Lam Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Lam Group, Inc. holds 483 shares of PFE stock, worth $12,137. This represents 0.01% of its overall portfolio holdings.

Number of Shares
483
Previous 483 -0.0%
Holding current value
$12,137
Previous $13.5 Million 99.9%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $78 - $101
-3 Reduced 0.62%
483 $13.9 Million
Q4 2022

Jan 12, 2023

BUY
$41.75 - $54.5 $20,290 - $26,487
486 New
486 $24.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lam Group, Inc. Portfolio

Follow Lam Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lam Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lam Group, Inc. with notifications on news.